(Q48034793)

7 February 2018

title

Minor modifications of a cholecystokinin-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties (English)

1 reference

7 February 2018

1 reference

M Beinborn

1

1 reference

7 February 2018

S M Quinn

series ordinal

2

1 reference

7 February 2018

A S Kopin

series ordinal

3

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

7 February 2018

Journal of Biological Chemistry

published in

1 reference

7 February 2018

volume

273

1 reference

7 February 2018

issue

23

1 reference

7 February 2018

page(s)

14146-14151

1 reference

7 February 2018

Structure and function of G protein-coupled receptors

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

The two-state model of receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Biological actions of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Mutations in G proteins and G protein-coupled receptors in endocrine disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine Hm1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosph

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Non-peptide angiotensin agonist. Functional and molecular interaction with the AT1 receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

A nonpeptidyl growth hormone secretagogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.23.14146

21 January 2018

Identifiers

DOI

10.1074/JBC.273.23.14146

1 reference

7 February 2018

release_dvnbp2smpbh2hfdiktbb6sg27e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dvnbp2smpbh2hfdiktbb6sg27e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

7 February 2018